A Subset of Neutrophils Expressing Markers of Antigen-Presenting Cells in Human Visceral Leishmaniasis
Overview
Affiliations
Background: Visceral leishmaniasis (VL) is a potentially fatal parasitic disease associated with fever, cachexia and impaired protective T-cell responses against the parasite.
Methods: Peripheral blood leukocytes from 105 subjects with VL and healthy control subjects from the endemic region of Muzaffarpur, Bihar, India, were compared using flow cytometry and reverse-transcriptase quantitative polymerase chain reaction. Findings were correlated with clinical data.
Results: An expanded population of low-density neutrophils that expressed HLA-DR, CD80 and CD86 was observed in subjects with VL. This neutrophil population contracted after successful treatment of disease. Plasma from patients with acute VL was able to induce similar high-level HLA-DR expression in neutrophils from healthy subjects. HLA-DR neutrophils from subjects with VL did not stimulate T-cell proliferation, but they did express higher programmed cell death ligand-1 (PDL1) than other neutrophils, and lymphocytes of the same subjects expressed high programmed cell death 1 (PD1).
Conclusions: Patients with acute VL have expanded circulating low-density neutrophils expressing markers of antigen presentation, which diminish after treatment. Development of HLA-DR neutrophils is stimulated, at least in part, by components of plasma from patients with acute disease. Although we found no evidence that they act as antigen-presenting cells, these neutrophils expressed markers implicating a role in T-cell exhaustion.
Role of neutrophils in the pathogenesis of Post Kala-azar Dermal Leishmaniasis (PKDL).
Roy M, Sengupta R, Chakraborty B, Chatterjee U, von Stebut E, Kaye P PLoS Negl Trop Dis. 2024; 18(11):e0012655.
PMID: 39602398 PMC: 11602034. DOI: 10.1371/journal.pntd.0012655.
Dual neutrophil subsets exacerbate or suppress inflammation in tuberculosis via IL-1β or PD-L1.
Doz-Deblauwe E, Bounab B, Carreras F, Fahel J, Oliveira S, Lamkanfi M Life Sci Alliance. 2024; 7(7.
PMID: 38803236 PMC: 11109925. DOI: 10.26508/lsa.202402623.
Kausar G, Bhushan Chauhan S, Roy R, Verma V, Pandey S, Niyaz A PLoS Negl Trop Dis. 2024; 18(4):e0012112.
PMID: 38669292 PMC: 11108134. DOI: 10.1371/journal.pntd.0012112.
Bomfim L, Magalhaes L, Rodrigues L, Barreto A, Santos C, Dos Santos P Front Cell Infect Microbiol. 2022; 12:863986.
PMID: 35402286 PMC: 8988227. DOI: 10.3389/fcimb.2022.863986.
Mandala W J Blood Med. 2022; 13:1-10.
PMID: 35018127 PMC: 8742601. DOI: 10.2147/JBM.S343109.